Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 11, Pages 5767-5770Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01032-13
Keywords
-
Categories
Funding
- Fondo de Investigacion Sanitaria (FIS) [PI11/00167]
- Astellas Pharma
- FIS [CD09/00230, MS09/00055, FI12/00265, CD11/00110]
Ask authors/readers for more resources
We compared the ability of the EUCAST EDef 7.2 and the Etest to detect the susceptibility to micafungin of 160 Candida and non-Candida clinical isolates. Agreement was higher when Etest MICs were obtained after 24 h of incubation; essential agreement was 90%, and categorical agreement was >90%. False susceptibility was seen only for Candida krusei (10%), and false resistance was observed in 6% of the isolates, ranging from 2.6% (C. glabrata) to 13% (C. albicans).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available